.OncoC4 is taking AcroImmune-- as well as its own internal scientific production capabilities-- unde...
.Amgen has actually shared (PDF) the first stage 3 information on its own $400 million chronic eczem...
.Biogen and UCB's gamble on improving in to period 3 on the back of a failed study looks to have rep...
.Italian biotech Aptadir Rehabs has actually introduced along with the pledge that its pipeline of p...
.Wave Life Sciences has satisfied its own goal in a Duchenne muscular dystrophy (DMD) research study...
.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, using up the ...
.Achilles Rehabs has destroyed its technique. The English biotech is knocking off on its own clinica...
.Aligos Therapies is trumpeting a midstage win in metabolic-dysfunction linked steatohepatitis (MASH...
.Basilea Pharmaceutica's job building brand-new antifungals has received a significant boost coming ...
.Possessing currently gathered up the USA rights to Capricor Therapies' late-stage Duchenne muscle d...